register

Medical

The growing scope of Medical Affairs in an evolving ecosystem

Health Industry Hub | July 14, 2021 |
[Total: 1    Average: 5/5]

Medical: As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients, healthcare professionals and payors. This imperative is further accelerating the evolution of Medical Affairs as a strategic pillar of the organisation.

In an interview with Health Industry Hub, Dr David Grolman, explored the impact of the pandemic on Medical Affairs and medical science liaison (MSL) teams, the imperatives in optimising the value of the Medical Affairs function and what excites him most about the next generation of Medical Affairs teams.

Dr Grolman is the Medical Director of the Hospital Business Unit and Medical Affairs Cluster Lead of International Developed Markets at Pfizer Australia, New Zealand & Korea. He is also a past President and current Executive Secretary of the Australian Pharmaceutical Medical and Scientific Professionals Association (APPA).

Dr Grolman said “There are several changes that are coming. Real world evidence is a real key imperative that I think Medical Affairs will be playing a major role in. The level of scientific engagement that’s needed between HCPs in the pharmaceutical industry is getting tougher all the time. So we’ve moved to where the discussion is extremely scientific and this is because the areas of unmet medical need is more specific and very complex. The discussion that is needed is at a much higher scientific level so I think the role of Medical is just going to get bigger and bigger.

“There’s going to be a big role in global harmonisation of approval processes. To repeat the process again and again in every country in the world with the delays of getting medication to patients is becoming unacceptable. People want to see this rapid timeline maintained.

“The collection of real world data to maintain patient safety, I think, is a big issue and we now have the ability to utilise big data techniques to improve outcomes. So many exciting things on the horizon,” he noted.


Leadership & Management

Leadership Management Qualities - Leaving an inspirational legacy by taking action and making a difference, says Medicines Australia CEO

Leaving an inspirational legacy by taking action and making a difference, Medicines Australia CEO

Health Industry Hub | September 20, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the Pharma, […]

More


Human Resources

Human Resource Management - Winners revealed at 2021 Australian HR Awards; Johnson & Johnson the only healthcare company to secure a win

Winners revealed at 2021 Australian HR Awards; Johnson & Johnson the only healthcare company to secure a win

Health Industry Hub | September 20, 2021 |

Human Resources: The annual Australian HR Awards has been recognised as the leading independent awards event in the HR profession […]

More


News & Trends - Pharmaceuticals

Pharma News - MSD's Keytruda excels in early stage melanoma, reducing cancer recurrence post-surgery

MSD’s Keytruda excels in early stage melanoma, reducing cancer recurrence post-surgery

Health Industry Hub | September 20, 2021 |

Pharma News: Patients with stage IIB and IIC melanoma have a deep or ulcerated primary tumour. These patients occur in […]

More


News & Trends - Medical Technology

MedTech News - AAOS releases new trends from the hip and knee replacement registry

AAOS releases new trends from the hip and knee replacement registry

Health Industry Hub | September 20, 2021 |

MedTech News: The American Academy of Orthopaedic Surgeons (AAOS) Registry Program announced the availability of the American Joint Replacement Registry Program (AJRR) […]

More